183
Views
11
CrossRef citations to date
0
Altmetric
Editorial

Improving R&D productivity of pharmaceutical companies through public–private partnership: experiences from the Innovative Medicines Initiative

, &
Pages 545-548 | Published online: 09 Jan 2014

References

  • Balducci C, Forloni G. APP transgenic mice: their use and limitations. Neuromolecular Med. 13(2), 117–137 (2011).
  • Pifferi F, Rahman A, Languille S et al. Effects of dietary resveratrol on the sleep–wake cycle in the non-human primate gray mouse lemur (Microcebus murinus). Chronobiol. Int. 29(3), 261–270 (2012).
  • Languille S, Blanc S, Blin O et al. The grey mouse lemur: a non-human primate model for ageing studies. Ageing Res. Rev. 11(1), 150–162 (2012).
  • Baastrup C, Maersk-Moller CC, Nyengaard JR, Jensen TS, Finnerup NB. Spinal-, brainstem- and cerebrally mediated responses at- and below-level of a spinal cord contusion in rats: evaluation of pain-like behavior. Pain 151(3), 670–679 (2010).
  • Baastrup C, Jensen TS, Finnerup NB. Coexisting mechanical hypersensitivity and anxiety in a rat model of spinal cord injury and the effect of pregabalin, morphine, and midazolam treatment. Scandinavian Journal of Pain 2(3), 139–145 (2011).
  • Andrews N, Legg E, Lisak D et al. Spontaneous burrowing behaviour in the rat is reduced by Cipheral nerve injury or inflammation associated pain. Eur. J. Pain 16(4), 485–495 (2012).
  • Ravassard P, Hazhouz Y, Pechberty S et al. A genetically engineered human pancreatic ß cell line exhibiting glucose-inducible insulin secretion. J. Clin. Invest. 121(9), 3589–3597 (2011).
  • Obiol-Pardo C, Gomis-Tena J, Sanz F, Saiz J, Pastor M. A multiscale simulation system for the prediction of drug-induced cardiotoxicity. J. Chem. Inf. Model. 51(2), 483–492 (2011).
  • Taboureau O, Jørgensen FS. In silico predictions of hERG channel blockers in drug discovery: from ligand-based and target-based approaches to systems chemical biology. Comb. Chem. High Throughput Screen. 14(5), 375–387 (2011).
  • Matheis K, Laurie D, Andriamandroso C et al. A generic operational strategy to qualify translational safety biomarkers. Drug Discov. Today 16(13–14), 600–608 (2011).
  • Dieterle F, Schuppe-Koistinen I, Prats N et al. The European IMI SAFE-T Consortium: qualification of translational safety biomarkers. Toxicol Lett. 189(Suppl. 1), S157 (2009).
  • Taboureau O, Nielsen SK, Audouze K et al. ChemProt: a disease chemical biology database. Nucleic Acids Res. 39(Suppl. 1), D367–D372 (2011).
  • Bauer-Mehren A, Rautschka M, Sanz F, Furlong LI. DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks. Bioinformatics 26(22), 2924–2926 (2010).
  • Garcia-Serna R, Mestres J. Anticipating drug side effects by comparative pharmacology. Expert Opin. Drug Metab. Toxicol. 6(10), 1253–1263 (2010).
  • Briggs K, Cases M, Heard DJ et al. Inroads to predict in vivo toxicology – an introduction to the eTOX project. Int. J. Mol. Sci. 13(3), 3820–3846 (2012).
  • Audouze K, Grandjean P. Application of computational systems biology to explore environmental toxicity hazards. Environ. Health Perspect. 119(12), 1754–1759 (2011).
  • Bel EH, Sousa A, Fleming L et al. Unbiased Biomarkers for the Prediction of Respiratory Disease Outcome (U-BIOPRED) Consortium, Consensus Generation. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 66(10), 910–917 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.